CAF339-22 DNA paternity testing

Complete

Buyers

Value

£0

Classifications

  • Laboratory services

Tags

  • tender

Submission Deadline

3 years ago

Published

3 years ago

Description

'The Authority'  CAFCASS and CAFCASS CYMRU  is seeking a provider for DNA testing services in England and Wales. The Provider must be on the Government list of accredited testing laboratories at the time of tender submission and throughout the life of the contract.  Details of how to obtain accreditation are available at:  https://www.gov.uk/get-laboratory-accreditation-to-carry-out-paternity-tests 

As a national service, the Authority has a network of offices staffed by FCAs who routinely meet with children and families as part of their case work. At these offices suitably trained Cafcass officers [as set out in The Blood Tests (Evidence of Paternity) (Amendment) Regulations 2015] will supervise the self-collection of samples with mouth swabs. For the purposes of this specification this is known as 'Pathway A'. 'Pathway A has previously been the Authority's standard approach to testing. 'Pathway B' where the Provider is responsible for sample collection has also previously been used for exceptional use. The Authority is now seeking a model where either pathway can be utilised depending on service requirements. The Authority will retain responsibility for determining the appropriate pathway per sample collection. The successful provider must have the capacity and capability to make available sample collection through their own network of sample collectors for use as agreed with the Authority. Please note a sampler (sample collector) is defined as a person trained by the tester (provider), or under arrangements made by the tester (provider) as set out in The Blood Tests (Evidence of Paternity) (Amendment) Regulations 2015]. 

Details of this opportunity can be found on Pro-Contract 
https://procontract.due-north.com/Opportunities/Index?tabName=opportunities&resetFilter=True

Documents

Premium

Bypass the hassle of outdated portals. Get all the information you need right here, right now.

  • Contract Agreement

    The official contract terms, conditions, and scopes of work.

    Download
  • Award Notice

    Details on the tender award and selected suppliers.

    Download

Similar Contracts

Open

Toxicology Services - Drug and Alcohol Testing

The GPhC wishes to inform the market of our intention to procure the provision of Toxicology Services - Drug and Alcohol Testing. Where there are concerns regarding physical or mental health, specifically drug and alcohol misuse, the GPhC may necessitate a Pharmacy Registrant (donor) undergo medical assessment, forming part of a wider Fitness to Practise investigation. In such cases, Toxicology Services (drug and alcohol testing) will be required to ascertain: i. if substance(s), as specified by the GPhC, have been used by the donor. ii. if substance(s), as specified by the GPhC, are being used by the donor. Moreover, a Registrant may also be required to enter a period of 'medical supervision' - monitoring to confirm compliance with any restrictions on their registration. Here, Toxicology Services (drug and alcohol testing) will be required to verify fulfilment of conditions set. The purpose of this notice is to raise awareness of our upcoming Request for Quotation sourcing activity, gauge accurate levels of market interest, and receive feedback on prospective plans/requirements in advance of the formal procurement process; to be announced in October 2025. Scope of services will include, the: 1. Supply of Phlebotomists and Specimen Collectors -throughout Great Britain- to collect donor samples: hair (head and body), nail, saliva, blood and urine. 2. Undertaking of sample drug testing for, but not limited to amphetamines, benzodiazepines, cannabinoids, cocaine, hallucinogens, hypnotic substances, ketamine, mephedrone, methadone, methamphetamines (including MDMA and MDEA), novel psychoactive substances, opiates, opioids, sedatives, steroids and tramadol. 3. Undertaking of sample alcohol -ethanol- testing; including phosphatidyl ethanol (PEth), carbohydrate-deficient transferrin (CDT) and fatty acid ethyl esters (FAEE) biomarkers, and ethyl glucuronide (EtG). 4. Undertaking of liver blood testing, formerly known as liver function tests (LFT). 5. Undertaking of full blood count testing (FBC), including mean corpuscular volume testing (MCV). 6. Secure email provision of sample analysis results within 3 working days; including the provision of supplementary reports which interpret results in an accessible (free from technical jargon, where possible), clear and concise manner. 7. Provision of a Certificate of Analysis (CoA). 8. Provision of testimony in the capacity of an Independent Expert Witness (where donor samples are tested for legal purposes). N.B. the Service Provider remains responsible for ensuring staff are adequately trained to undertake this requirement, if requested. Please note, samples are to be collected at a donors' home residence, or a neutral site as determined by the Service Provider. We kindly ask that all interested suppliers complete and submit this response form to Anna Kitoki, at [email protected] by 17:00 on 02.09.2025. Any interest shown does not constitute a commitment to participate; and failure to show interest does not restrict suppliers from participating in this and/or any other procurement process run by the GPhC.

Katy Reed

Published 3 weeks ago

AI Bid Assistant

Our AI-powered tool to help you create winning bids is coming soon!

View Contract Source Save Contract

Organisation

Cafcass Procurement Team

[email protected]

3004564000

Timeline complete